Fetal bovine serum (FBS) is the most widely used growth supplement for cell culture media because of its high content of embryonic growth promoting factors. When used at appropriate concentrations it supplies many defined and undefined components that have been shown to satisfy specific metabolic requirements for the culture of cells.
The manufacturers of FBS are concentrated in North America, Australia, New Zealand and South America. The growth of FBS production has been modest for the past years, due to the deficiency of raw material supply. In 2017, the global sales volume of FBS has reached 655459 liters. The market of FBS is concentrated. Thermo Fisher is the largest manufacturer in the global, followed by GE Healthcare and Merck. The consumption regions and supply regions of FBS are quite different. The consumers are mainly concentrated in USA and Europe, followed by Japan.
According to this study, over the next five years the Fetal Bovine Serum market will register a 7.4% CAGR in terms of revenue, the global market size will reach US$ 1500 million by 2024, from US$ 970 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Fetal Bovine Serum business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Fetal Bovine Serum market by product type, application, key manufacturers and key regions and countries.
This study considers the Fetal Bovine Serum value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3: and forecast to 2024 in section 11.7.
North America-sourced
South America-sourced
Australia-sourced
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4: and forecast to 2024 in section 11.8.
Scientific Research
Industrial Production
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher
GE Healthcare
Sigma-Aldrich
Merck
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
PAN-Biotech
VWR
Corning
Animal Technologies
Serana
WISENT
Peak Serum
Seroxlab
NorthBio
Bio Nutrientes Brasil
Lanzhou Minhai
Zhejiang Tianhang Biotechnology
ExCell Bio
Jin Yuan Kang
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Fetal Bovine Serum consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Fetal Bovine Serum market by identifying its various subsegments.
Focuses on the key global Fetal Bovine Serum manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Fetal Bovine Serum with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Fetal Bovine Serum submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
